Shopping Cart 0
Cart Subtotal
AED 0

Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2019

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 14680

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 29360

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 44040

Details

Continuous Glucose Monitoring Systems-Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, "Continuous Glucose Monitoring Systems-Medical Devices Pipeline Assessment, 2019", provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Continuous Glucose Monitoring Systems under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Continuous Glucose Monitoring Systems Overview

3 Products under Development

3.1 Continuous Glucose Monitoring Systems-Pipeline Products by Stage of Development

3.2 Continuous Glucose Monitoring Systems-Pipeline Products by Territory

3.3 Continuous Glucose Monitoring Systems-Pipeline Products by Regulatory Path

3.4 Continuous Glucose Monitoring Systems-Pipeline Products by Estimated Approval Date

3.5 Continuous Glucose Monitoring Systems-Ongoing Clinical Trials

4 Continuous Glucose Monitoring Systems-Pipeline Products under Development by Companies

4.1 Continuous Glucose Monitoring Systems Companies-Pipeline Products by Stage of Development

4.2 Continuous Glucose Monitoring Systems-Pipeline Products by Stage of Development

5 Continuous Glucose Monitoring Systems Companies and Product Overview

5.1 A. Menarini Diagnostics Srl Company Overview

5.2 Abbott Diabetes Care Inc Company Overview

5.3 Advanced Biosensors-Ohio LLC (Inactive) Company Overview

5.4 Advanced Medical Electronics Corp Company Overview

5.5 Arkal Medical, Inc. (Inactive) Company Overview

5.6 Ascensia Diabetes Care Holdings AG Company Overview

5.7 Azurite Technologies, Inc. (Inactive) Company Overview

5.8 Biorasis Inc Company Overview

5.9 Biovotion AG Company Overview

5.10 Brigham and Women's Hospital Company Overview

5.11 CALISTO MEDICAL, INC. (Inactive) Company Overview

5.12 CGM3 Ltd Company Overview

5.13 City, University of London Company Overview

5.14 Columbia University Company Overview

5.15 ConvaTec Group Plc Company Overview

5.16 Cyber Medical Ltd Company Overview

5.17 Debiotech SA Company Overview

5.18 DexCom Inc Company Overview

5.19 DirectSens GmbH Company Overview

5.20 Echo Therapeutics Inc Company Overview

5.21 Ecole Polytechnique Federale de Lausanne Company Overview

5.22 eLutions Integrated Systems, Inc. Company Overview

5.23 EyeSense GmbH Company Overview

5.24 Flowsion A/S Company Overview

5.25 Gili Medical Ltd Company Overview

5.26 Globe Medical Tech Inc (Inactive) Company Overview

5.27 GlucoLight Corporation (Inactive) Company Overview

5.28 Glucometrix AG Company Overview

5.29 Glucosense Diagnostics Ltd (Inactive) Company Overview

5.30 GlucoSet AS Company Overview

5.31 Glucovation Inc Company Overview

5.32 GluMetrics Inc Company Overview

5.33 Glusense Ltd Company Overview

5.34 GlySens Inc Company Overview

5.35 G-Sense Ltd. Company Overview

5.36 iGlyko, Inc. (Inactive) Company Overview

5.37 Indigo Diabetes NV Company Overview

5.38 Innovosens AB Company Overview

5.39 Insulet Corp Company Overview

5.40 Integrated Medical Sensors Company Overview

5.41 Integrity Applications Ltd Company Overview

5.42 Invivosense ASA (Inactive) Company Overview

5.43 I-Sens Inc Company Overview

5.44 iSense Corporation (Inactive) Company Overview

5.45 Keratin Biosciences Inc Company Overview

5.46 Know Labs Inc Company Overview

5.47 KTH Royal Institute of Technology Company Overview

5.48 LEMM Technologies, LLC Company Overview

5.49 Massachusetts Institute of Technology Company Overview

5.50 Medical Wireless Sensing Ltd Company Overview

5.51 Medtronic Diabetes Company Overview

5.52 Medtronic plc Company Overview

5.53 Mellitor Ltd Company Overview

5.54 Metronom Health Inc Company Overview

5.55 mobiLIFE Company Overview

5.56 Nemaura Medical Inc Company Overview

5.57 Newton Photonics Inc Company Overview

5.58 Northwestern University Company Overview

5.59 Orsus Medical Ltd Company Overview

5.60 PKvitality Company Overview

5.61 PositiveID Corp Company Overview

5.62 Prediktor Medical AS Company Overview

5.63 Profusa Inc Company Overview

5.64 Purdue University Company Overview

5.65 San Meditech (Huzhou) Co., Ltd. Company Overview

5.66 Senseonics Holdings Inc Company Overview

5.67 SensiVida Medical Technologies, Inc. (Inactive) Company Overview

5.68 Senzime AB Company Overview

5.69 Singapore Biomicro Pte Ltd Company Overview

5.70 Socrates Health Solutions, Inc. Company Overview

5.71 Stony Brook University Company Overview

5.72 Swansea University Company Overview

5.73 Tenax Therapeutics Inc Company Overview

5.74 Terumo Corp Company Overview

5.75 Texas A&M University Company Overview

5.76 Ultradian Diagnostics LLC Company Overview

5.77 University of California Berkeley Company Overview

5.78 University of California Irvine Company Overview

5.79 University of California San Diego Company Overview

5.80 University of South Carolina Company Overview

5.81 University of South Florida Company Overview

5.82 University of Technology Sydney Company Overview

5.83 University of Texas at Arlington Company Overview

5.84 VeriTeQ Corporation Company Overview

5.85 Vytrace, Inc. Company Overview

5.86 WaveForm Technologies Inc Company Overview

5.87 Zyvex Corp Company Overview

6 Continuous Glucose Monitoring Systems- Recent Developments

6.1 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health

6.2 Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019

6.3 Jul 18, 2019: Nemaura Medical appoints Chris Avery as vice president of global business operations to support global commercial launch of SugarBEAT

6.4 Jul 17, 2019: Know Labs announces significant pre-clinical progress of uband non-invasive continuous glucose monitor

6.5 Jul 10, 2019: Nemaura Medical submits de novo 510(k) application for SugarBEAT to the U.S. Food and Drug Administration

6.6 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility

6.7 Jun 27, 2019: FDA warns patients and health care providers about potential cybersecurity concerns with certain Medtronic insulin pumps

6.8 Jun 25, 2019: ConvaTec Group: Board Change

6.9 Jun 18, 2019: Senzime contracts new CFO

6.10 Jun 17, 2019: Nemaura provides fiscal 2019 year-end business update

6.11 Jun 17, 2019: Abbott reports second-quarter 2019 results

6.12 Jun 11, 2019: Abbott's FreeStyle device helps significantly reduce glucose levels

6.13 Jun 10, 2019: Real-World data from Guardian Connect and Sugar.IQ reveal improved diabetes outcomes

6.14 Jun 08, 2019: Pilot Study Shows That Investigational Interconnected Diabetes Management Solution From Ascensia Significantly Reduced HbA1c in People With Type 2 Diabetes

6.15 Jun 08, 2019: Medtronic initiates pivotal trial for next-generation Guardian Continuous Glucose Monitoring Sensor

6.16 Jun 07, 2019: Senzime's board member Ulf Lindskog has passed away

6.17 Jun 06, 2019: Senseonics announces FDA approval for a non-adjunctive indication (Dosing Claim) for the Eversense 90-day CGM System

6.18 Jun 05, 2019: Senseonics to present real-world, long-term safety data of the First Implantable CGM Sensor at the American Diabetes Association's 79th Scientific Sessions

6.19 Jun 04, 2019: Medtronic awarded USD 150M contract from Defense Logistics Agency

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer


List Of Figure

1.2 List of Figures

Figure 1: Continuous Glucose Monitoring Systems-Pipeline Products by Stage of Development

Figure 2: Continuous Glucose Monitoring Systems-Pipeline Products by Territory

Figure 3: Continuous Glucose Monitoring Systems-Pipeline Products by Regulatory Path

Figure 4: Continuous Glucose Monitoring Systems-Pipeline Products by Estimated Approval Date

Figure 5: Continuous Glucose Monitoring Systems-Ongoing Clinical Trials


List Of Table

1.1 List of Tables

Table 1: Continuous Glucose Monitoring Systems-Pipeline Products by Stage of Development

Table 2: Continuous Glucose Monitoring Systems-Pipeline Products by Territory

Table 3: Continuous Glucose Monitoring Systems-Pipeline Products by Regulatory Path

Table 4: Continuous Glucose Monitoring Systems-Pipeline Products by Estimated Approval Date

Table 5: Continuous Glucose Monitoring Systems-Ongoing Clinical Trials

Table 6: Continuous Glucose Monitoring Systems Companies-Pipeline Products by Stage of Development

Table 7: Continuous Glucose Monitoring Systems-Pipeline Products by Stage of Development

Table 8: A. Menarini Diagnostics Srl Pipeline Products & Ongoing Clinical Trials Overview

Table 9: GlucoMen Day-Product Status

Table 10: GlucoMen Day-Product Description

Table 11: Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 12: FreeStyle Libre Flash Glucose Monitoring System-Children-Product Status

Table 13: FreeStyle Libre Flash Glucose Monitoring System-Children-Product Description

Table 14: FreeStyle Libre Glucose Monitoring System-Consumer Version-Product Status

Table 15: FreeStyle Libre Glucose Monitoring System-Consumer Version-Product Description

Table 16: Abbott Diabetes Care Inc-Ongoing Clinical Trials Overview

Table 17: FreeStyle Libre Flash Glucose Monitoring System-Children-A Comparative Study on the Accuracy and Usability Between the Dexcom G5 Mobile CGM System and the FreeStyle Flash Glucose Monitoring System

Table 18: FreeStyle Libre Flash Glucose Monitoring System-Children-An Evaluation of the Usability, Skin Reactions and Accuracy of the FreeStyle Libre Flash Glucose Monitoring System

Table 19: FreeStyle Libre Flash Glucose Monitoring System-Children-FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients

Table 20: FreeStyle Libre Flash Glucose Monitoring System-Children-Individualized Carbohydrate Intake Strategy to Improve Blood Glucose Control During Team Sports in Children and Adolescents with Type 1 Diabetes: A Carowanis Camp Study

Table 21: FreeStyle Libre Flash Glucose Monitoring System-Children-Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial

Table 22: FreeStyle Libre Flash Glucose Monitoring System-Children-Prediction and Prevention of Nocturnal Hypoglycemia in Persons with Type 1 Diabetes with Multiple Doses of Insulin using Machine Learning Techniques

Table 23: Advanced Biosensors-Ohio LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 24: My Medibit-Product Status

Table 25: My Medibit-Product Description

Table 26: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview

Table 27: Continuous Glucose Monitor-Product Status

Table 28: Continuous Glucose Monitor-Product Description

Table 29: Arkal Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 30: GlucoPod CGM System-Product Status

Table 31: GlucoPod CGM System-Product Description

Table 32: Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview

Table 33: CONTOUR PLUS ONE-Product Status

Table 34: CONTOUR PLUS ONE-Product Description

Table 35: Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 36: Blood Glucose Sensor-Product Status

Table 37: Blood Glucose Sensor-Product Description

Table 38: Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 39: Glucowizzard-Product Status

Table 40: Glucowizzard-Product Description

Table 41: Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview

Table 42: VSM 3 Glucose Monitoring System-Product Status

Table 43: VSM 3 Glucose Monitoring System-Product Description

Table 44: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview

Table 45: Fluorescence Measurement Device-Product Status

Table 46: Fluorescence Measurement Device-Product Description

Table 47: CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 48: Glucoband-Product Status

Table 49: Glucoband-Product Description

Table 50: CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

A. Menarini Diagnostics Srl, GlucoMen Day, Diabetes Mellitus; Abbott Diabetes Care Inc, FreeStyle Libre Flash Glucose Monitoring System - Children, Diabetes Mellitus; Abbott Diabetes Care Inc, FreeStyle Libre Glucose Monitoring System - Consumer Version, Diabetes Mellitus; Advanced Biosensors-Ohio LLC (Inactive), My Medibit, Diabetes Mellitus; Advanced Medical Electronics Corp, Continuous Glucose Monitor, Diabetes Mellitus; Arkal Medical, Inc. (Inactive), GlucoPod CGM System, MicroTip Technology, Type I Diabetes Mellitus; Arkal Medical, Inc. (Inactive), GlucoPod CGM System, MicroTip Technology, Type II Diabetes Mellitus; Ascensia Diabetes Care Holdings AG, CONTOUR PLUS ONE, No Coding Technology, Diabetes Mellitus; Azurite Technologies, Inc. (Inactive), Blood Glucose Sensor, Type I Diabetes Mellitus; Biorasis Inc, Glucowizzard, Type I Diabetes Mellitus; Biovotion AG, VSM 3 Glucose Monitoring System, Impedance Spectroscopy, Diabetes Mellitus; Brigham and Women's Hospital, Fluorescence Measurement Device, Diabetes Mellitus; CALISTO MEDICAL, INC. (Inactive), Glucoband, Bio-electromagnetic Resonance Technology, Diabetes Mellitus; CGM3 Ltd, Miniaturized Implantable Continuous Glucose Monitor, Diabetes Mellitus; City, University of London, Non-Invasive Glucose Monitor, Dynamic Pulsatile Spectroscopy (DPS) Technology, Diabetes Mellitus; Columbia University, Wearable Continuous Blood Glucose Monitoring Device, Diabetes Mellitus; ConvaTec Group Plc, Closed Loop Continuous Glucose Monitoring System, Diabetes Mellitus; Cyber Medical Ltd, Cybersensors Continuous Glucose Sensor, Biosensor Technology, Diabetes Mellitus; Debiotech SA, Integrated iSense CGM And JewelPUMP, Type I Diabetes Mellitus; Debiotech SA, Integrated iSense CGM And JewelPUMP, Type II Diabetes Mellitus; DexCom Inc, Dexcom G6 CGM System, Diabetes Mellitus; DexCom Inc, Dexcom G7 CGM System, Diabetes Mellitus; DexCom Inc, First-Gen Verily Sensor, Diabetes Mellitus; DirectSens GmbH, 3rd Generation Glucose Sensor, Diabetes Mellitus; DirectSens GmbH, Continuous Blood Glucose Monitoring System, Diabetes Mellitus; Echo Therapeutics Inc, Gen 2 Symphony CGM System, Diabetes Mellitus; Echo Therapeutics Inc, NextGen System, Diabetes Mellitus; Echo Therapeutics Inc, Symphony tCGM System - Home, Type I Diabetes Mellitus; Echo Therapeutics Inc, Symphony tCGM System - Home, Type II Diabetes Mellitus; Echo Therapeutics Inc, Symphony tCGM System - Hospital Critical Care, Type I Diabetes Mellitus; Echo Therapeutics Inc, Symphony tCGM System - Hospital Critical Care, Type II Diabetes Mellitus; Ecole Polytechnique Federale de Lausanne, Viscosimetric Glucose Sensor, Diabetes Mellitus; eLutions Integrated Systems, Inc., Optically-Efficient Miniaturized Raman Optical System, Diabetes Mellitus; EyeSense GmbH, FiberSense System, FiberSense Technology, Diabetes Mellitus; Flowsion A/S, Diramo System, Diabetes Mellitus; Flowsion A/S, Glycostat, Diabetes Mellitus; Gili Medical Ltd, Diawatch, Hypoglycemia; Globe Medical Tech Inc (Inactive), Continuous Glucose Monitoring Device, Diabetes Mellitus; GlucoLight Corporation (Inactive), SENTRIS-100, Optical Coherence Tomography Technology, Diabetes Mellitus; Glucometrix AG, Non-Invasive Blood Glucose Monitoring Device, Quantum Cascade Laser Technology, Diabetes Mellitus; Glucosense Diagnostics Ltd (Inactive), Non-Invasive Blood Glucose Monitor, Type I Diabetes Mellitus; Glucosense Diagnostics Ltd (Inactive), Non-Invasive Blood Glucose Monitor, Type II Diabetes Mellitus; GlucoSet AS, GlucoSet Sensor, Diabetes Mellitus; Glucovation Inc, SugarSenz Continuous Glucose Monitor, Diabetes Mellitus; GluMetrics Inc, GluCath Intravascular Continuous Glucose Monitor, Diabetes Mellitus; Glusense Ltd, Glyde CGM, Diabetes Mellitus; GlySens Inc, Eclipse ICGM System, Diabetes Mellitus; GlySens Inc, Second Generation ICGM System, Diabetes Mellitus; G-Sense Ltd., G-Sense Device, Diabetes Mellitus; iGlyko, Inc. (Inactive), iGlyko System, Blood-Glucose Sensor Technology, Diabetes Mellitus; Indigo Diabetes NV, Needle-Free Glucose Sensor, Diabetes Mellitus; Innovosens AB, Diabsens, Diabetes Mellitus; Insulet Corp, Integrated CGM With Next Gen OmniPod System PDM, Diabetes Mellitus; Integrated Medical Sensors, Implantable Continuous Glucose Monitor, Type I Diabetes Mellitus; Integrity Applications Ltd, GlucoTrack - DF-C, Diabetes Mellitus; Integrity Applications Ltd, GlucoTrack DF-F - Pre-diabetes, Diabetes Mellitus; Integrity Applications Ltd, GlucoTrack DF-F, Type II Diabetes Mellitus; Invivosense ASA (Inactive), IvSCGM Biosensor, Smart Hydrogel Fiber Optic Sensing Technology, Diabetes Mellitus; I-Sens Inc, Continuous Glucose Monitor, Diabetes Mellitus; iSense Corporation (Inactive), iSense CGM, Diabetes Mellitus; Keratin Biosciences Inc, Illume, MicroCHIPS Technology, Diabetes Mellitus; Know Labs Inc, UBAND, Diabetes Mellitus; KTH Royal Institute of Technology, Microneedle Patch - Glucose Monitoring, Diabetes Mellitus; LEMM Technologies, LLC, Non-Invasive Blood Glucose Monitor, Type I Diabetes Mellitus; LEMM Technologies, LLC, Non-Invasive Blood Glucose Monitor, Type II Diabetes Mellitus; Massachusetts Institute of Technology, Glucose Sensitive Tattoo, Diabetes Mellitus; Massachusetts Institute of Technology, Implantable Glucose Sensor, Diabetes Mellitus; Medical Wireless Sensing Ltd, GlucoWiSe, Diabetes Mellitus; Medtronic Diabetes, Combo Set Glucose Monitoring System, Diabetes Mellitus; Medtronic Diabetes, Enhanced Enlite Glucose Sensor, Diabetes Mellitus; Medtronic Diabetes, Guardian Connect Mobile CGM System, Diabetes Mellitus; Medtronic Diabetes, Harmony 1 Sensor, Type I Diabetes Mellitus; Medtronic Diabetes, Harmony 1 Sensor, Type II Diabetes Mellitus; Medtronic Diabetes, Harmony 2 Sensor, Diabetes Mellitus; Medtronic Diabetes, iPro 3 Glucose Monitoring System, Diabetes Mellitus; Medtronic Diabetes, ipro 4 Glucose Monitoring System, Diabetes Mellitus; Medtronic Diabetes, ipro 5 Glucose Monitoring System Sensor, Diabetes Mellitus; Medtronic Diabetes, Synergy Sensor, SmartGuard Technology, Diabetes Mellitus; Medtronic plc, Zeus Next Generation Guardian Sensor, Diabetes Mellitus; Mellitor Ltd, Mellitor Sensor, Mellitor Sensor Technology, Diabetes Mellitus; Metronom Health Inc, CGM System, Diabetes Mellitus; mobiLIFE, GlucoReader, Diabetes Mellitus; Nemaura Medical Inc, sugarBEAT, Beat Technology, Diabetes Mellitus; Newton Photonics Inc, Non-invasive Blood Glucose Monitor, Optical Coherence Tomography Technology, Diabetes Mellitus; Northwestern University, Continuous Glucose Sensor, Diabetes Mellitus; Orsus Medical Ltd, Non-Invasive Blood Glucose Monitor, Diabetes Mellitus; PKvitality, K'Watch Glucose, SkinTaste Technology, Diabetes Mellitus; PositiveID Corp, Fully Synthetic Glucose Sensing System, Diabetes Mellitus; Prediktor Medical AS, BioMKR one, Type I Diabetes Mellitus; Profusa Inc, Non-enzymatic Glucose Sensor, Diabetes Mellitus; Purdue University, Soft Contact Lens - Glucose Monitoring, Diabetes Mellitus; Purdue University, Soft Contact Lens - Glucose Monitoring, Ocular Diseases; Purdue University, Soft Contact Lens - Glucose Monitoring, Ocular Pain; San Meditech (Huzhou) Co., Ltd., Dynamic Glucose Monitoring System, Diabetes Mellitus; Senseonics Holdings Inc, Eversense XL CGM System, Diabetes Mellitus; SensiVida Medical Technologies, Inc. (Inactive), Glucose Monitoring System, Multispectral Image Processing Technology, Diabetes Mellitus; Senzime AB, CliniSenz, Biosensor Technology, Diabetes Mellitus; Singapore Biomicro Pte Ltd, Implantable Blood Glucose Monitoring Device, Diabetes Mellitus; Socrates Health Solutions, Inc., Companion CM, Diabetes Mellitus; Stony Brook University, GlucoREAD Patch, Type I Diabetes Mellitus; Stony Brook University, GlucoREAD Patch, Type II Diabetes Mellitus; Swansea University, Flash Glucose Monitoring Device, Type I Diabetes Mellitus; Swansea University, Hi-Tech Diabetes Blood Glucose Monitor, Diabetes Mellitus; Tenax Therapeutics Inc, Glucose Biosensor, Diabetes Mellitus; Terumo Corp, CMOS Image Glucose Sensor, Diabetes Mellitus; Terumo Corp, High Accuracy CGM, Diabetes Mellitus; Texas A&;M University, Minimally Invasive Glucose Monitoring System, Diabetes Mellitus; Ultradian Diagnostics LLC, Biologue, Diabetes Mellitus; University of California Berkeley, Dropsense Continuous Glucose Monitor, Diabetes Mellitus; University of California Irvine, Implantable Device - Diabetes Mellitus, Type I Diabetes Mellitus; University of California Irvine, Implantable Device - Diabetes Mellitus, Type II Diabetes Mellitus; University of California San Diego, Glucose Monitoring Tattoo, Diabetes Mellitus; University of South Carolina, Continuous Glucose Monitoring System, Diabetes Mellitus; University of South Florida, Long Term Silicon Carbide (SiC) RF Antenna, Diabetes Mellitus; University of Technology Sydney, Hypo Detection System, Hypoglycemia; University of Texas at Arlington, Nanotechnology Based Glucose Monitoring Device, Diabetes Mellitus; VeriTeQ Corporation, GlucoChip, Diabetes Mellitus; Vytrace, Inc., Continuous Glucose Monitoring Device, Diabetes Mellitus; WaveForm Technologies Inc, Continuous Glucose Monitoring System, Diabetes Mellitus; Zyvex Corp, GeNI, Diabetes Mellitus


Companies

A. Menarini Diagnostics Srl

Abbott Diabetes Care Inc

Advanced Biosensors-Ohio LLC

Advanced Medical Electronics Corp

Arkal Medical, Inc.

Ascensia Diabetes Care Holdings AG

Azurite Technologies, Inc.

Biorasis Inc

Biovotion AG

Brigham and Women's Hospital

CALISTO MEDICAL, INC.

CGM3 Ltd

City, University of London

Columbia University

ConvaTec Group Plc

Cyber Medical Ltd

Debiotech SA

DexCom Inc

DirectSens GmbH

Echo Therapeutics Inc

Ecole Polytechnique Federale de Lausanne

eLutions Integrated Systems, Inc.

EyeSense GmbH

Flowsion A/S

Gili Medical Ltd

Globe Medical Tech Inc

GlucoLight Corporation

Glucometrix AG

Glucosense Diagnostics Ltd

GlucoSet AS

Glucovation Inc

GluMetrics Inc

Glusense Ltd

GlySens Inc

G-Sense Ltd.

iGlyko, Inc.

Indigo Diabetes NV

Innovosens AB

Insulet Corp

Integrated Medical Sensors

Integrity Applications Ltd

Invivosense ASA

I-Sens Inc

iSense Corporation

Keratin Biosciences Inc

Know Labs Inc

KTH Royal Institute of Technology

LEMM Technologies, LLC

Massachusetts Institute of Technology

Medical Wireless Sensing Ltd

Medtronic Diabetes

Medtronic plc

Mellitor Ltd

Metronom Health Inc

mobiLIFE

Nemaura Medical Inc

Newton Photonics Inc

Northwestern University

Orsus Medical Ltd

PKvitality

PositiveID Corp

Prediktor Medical AS

Profusa Inc

Purdue University

San Meditech (Huzhou) Co., Ltd.

Senseonics Holdings Inc

SensiVida Medical Technologies, Inc.

Senzime AB

Singapore Biomicro Pte Ltd

Socrates Health Solutions, Inc.

Stony Brook University

Swansea University

Tenax Therapeutics Inc

Terumo Corp

Texas A&M University

Ultradian Diagnostics LLC

University of California Berkeley

University of California Irvine

University of California San Diego

University of South Carolina

University of South Florida

University of Technology Sydney

University of Texas at Arlington

VeriTeQ Corporation

Vytrace, Inc.

WaveForm Technologies Inc

Zyvex Corp

Company Profile

Company Profile Title

Continuous Glucose Monitoring Systems-Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, "Continuous Glucose Monitoring Systems-Medical Devices Pipeline Assessment, 2019", provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Continuous Glucose Monitoring Systems under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Scope

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Continuous Glucose Monitoring Systems Overview

3 Products under Development

3.1 Continuous Glucose Monitoring Systems-Pipeline Products by Stage of Development

3.2 Continuous Glucose Monitoring Systems-Pipeline Products by Territory

3.3 Continuous Glucose Monitoring Systems-Pipeline Products by Regulatory Path

3.4 Continuous Glucose Monitoring Systems-Pipeline Products by Estimated Approval Date

3.5 Continuous Glucose Monitoring Systems-Ongoing Clinical Trials

4 Continuous Glucose Monitoring Systems-Pipeline Products under Development by Companies

4.1 Continuous Glucose Monitoring Systems Companies-Pipeline Products by Stage of Development

4.2 Continuous Glucose Monitoring Systems-Pipeline Products by Stage of Development

5 Continuous Glucose Monitoring Systems Companies and Product Overview

5.1 A. Menarini Diagnostics Srl Company Overview

5.2 Abbott Diabetes Care Inc Company Overview

5.3 Advanced Biosensors-Ohio LLC (Inactive) Company Overview

5.4 Advanced Medical Electronics Corp Company Overview

5.5 Arkal Medical, Inc. (Inactive) Company Overview

5.6 Ascensia Diabetes Care Holdings AG Company Overview

5.7 Azurite Technologies, Inc. (Inactive) Company Overview

5.8 Biorasis Inc Company Overview

5.9 Biovotion AG Company Overview

5.10 Brigham and Women's Hospital Company Overview

5.11 CALISTO MEDICAL, INC. (Inactive) Company Overview

5.12 CGM3 Ltd Company Overview

5.13 City, University of London Company Overview

5.14 Columbia University Company Overview

5.15 ConvaTec Group Plc Company Overview

5.16 Cyber Medical Ltd Company Overview

5.17 Debiotech SA Company Overview

5.18 DexCom Inc Company Overview

5.19 DirectSens GmbH Company Overview

5.20 Echo Therapeutics Inc Company Overview

5.21 Ecole Polytechnique Federale de Lausanne Company Overview

5.22 eLutions Integrated Systems, Inc. Company Overview

5.23 EyeSense GmbH Company Overview

5.24 Flowsion A/S Company Overview

5.25 Gili Medical Ltd Company Overview

5.26 Globe Medical Tech Inc (Inactive) Company Overview

5.27 GlucoLight Corporation (Inactive) Company Overview

5.28 Glucometrix AG Company Overview

5.29 Glucosense Diagnostics Ltd (Inactive) Company Overview

5.30 GlucoSet AS Company Overview

5.31 Glucovation Inc Company Overview

5.32 GluMetrics Inc Company Overview

5.33 Glusense Ltd Company Overview

5.34 GlySens Inc Company Overview

5.35 G-Sense Ltd. Company Overview

5.36 iGlyko, Inc. (Inactive) Company Overview

5.37 Indigo Diabetes NV Company Overview

5.38 Innovosens AB Company Overview

5.39 Insulet Corp Company Overview

5.40 Integrated Medical Sensors Company Overview

5.41 Integrity Applications Ltd Company Overview

5.42 Invivosense ASA (Inactive) Company Overview

5.43 I-Sens Inc Company Overview

5.44 iSense Corporation (Inactive) Company Overview

5.45 Keratin Biosciences Inc Company Overview

5.46 Know Labs Inc Company Overview

5.47 KTH Royal Institute of Technology Company Overview

5.48 LEMM Technologies, LLC Company Overview

5.49 Massachusetts Institute of Technology Company Overview

5.50 Medical Wireless Sensing Ltd Company Overview

5.51 Medtronic Diabetes Company Overview

5.52 Medtronic plc Company Overview

5.53 Mellitor Ltd Company Overview

5.54 Metronom Health Inc Company Overview

5.55 mobiLIFE Company Overview

5.56 Nemaura Medical Inc Company Overview

5.57 Newton Photonics Inc Company Overview

5.58 Northwestern University Company Overview

5.59 Orsus Medical Ltd Company Overview

5.60 PKvitality Company Overview

5.61 PositiveID Corp Company Overview

5.62 Prediktor Medical AS Company Overview

5.63 Profusa Inc Company Overview

5.64 Purdue University Company Overview

5.65 San Meditech (Huzhou) Co., Ltd. Company Overview

5.66 Senseonics Holdings Inc Company Overview

5.67 SensiVida Medical Technologies, Inc. (Inactive) Company Overview

5.68 Senzime AB Company Overview

5.69 Singapore Biomicro Pte Ltd Company Overview

5.70 Socrates Health Solutions, Inc. Company Overview

5.71 Stony Brook University Company Overview

5.72 Swansea University Company Overview

5.73 Tenax Therapeutics Inc Company Overview

5.74 Terumo Corp Company Overview

5.75 Texas A&M University Company Overview

5.76 Ultradian Diagnostics LLC Company Overview

5.77 University of California Berkeley Company Overview

5.78 University of California Irvine Company Overview

5.79 University of California San Diego Company Overview

5.80 University of South Carolina Company Overview

5.81 University of South Florida Company Overview

5.82 University of Technology Sydney Company Overview

5.83 University of Texas at Arlington Company Overview

5.84 VeriTeQ Corporation Company Overview

5.85 Vytrace, Inc. Company Overview

5.86 WaveForm Technologies Inc Company Overview

5.87 Zyvex Corp Company Overview

6 Continuous Glucose Monitoring Systems- Recent Developments

6.1 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health

6.2 Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019

6.3 Jul 18, 2019: Nemaura Medical appoints Chris Avery as vice president of global business operations to support global commercial launch of SugarBEAT

6.4 Jul 17, 2019: Know Labs announces significant pre-clinical progress of uband non-invasive continuous glucose monitor

6.5 Jul 10, 2019: Nemaura Medical submits de novo 510(k) application for SugarBEAT to the U.S. Food and Drug Administration

6.6 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility

6.7 Jun 27, 2019: FDA warns patients and health care providers about potential cybersecurity concerns with certain Medtronic insulin pumps

6.8 Jun 25, 2019: ConvaTec Group: Board Change

6.9 Jun 18, 2019: Senzime contracts new CFO

6.10 Jun 17, 2019: Nemaura provides fiscal 2019 year-end business update

6.11 Jun 17, 2019: Abbott reports second-quarter 2019 results

6.12 Jun 11, 2019: Abbott's FreeStyle device helps significantly reduce glucose levels

6.13 Jun 10, 2019: Real-World data from Guardian Connect and Sugar.IQ reveal improved diabetes outcomes

6.14 Jun 08, 2019: Pilot Study Shows That Investigational Interconnected Diabetes Management Solution From Ascensia Significantly Reduced HbA1c in People With Type 2 Diabetes

6.15 Jun 08, 2019: Medtronic initiates pivotal trial for next-generation Guardian Continuous Glucose Monitoring Sensor

6.16 Jun 07, 2019: Senzime's board member Ulf Lindskog has passed away

6.17 Jun 06, 2019: Senseonics announces FDA approval for a non-adjunctive indication (Dosing Claim) for the Eversense 90-day CGM System

6.18 Jun 05, 2019: Senseonics to present real-world, long-term safety data of the First Implantable CGM Sensor at the American Diabetes Association's 79th Scientific Sessions

6.19 Jun 04, 2019: Medtronic awarded USD 150M contract from Defense Logistics Agency

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer


List Of Figure

1.2 List of Figures

Figure 1: Continuous Glucose Monitoring Systems-Pipeline Products by Stage of Development

Figure 2: Continuous Glucose Monitoring Systems-Pipeline Products by Territory

Figure 3: Continuous Glucose Monitoring Systems-Pipeline Products by Regulatory Path

Figure 4: Continuous Glucose Monitoring Systems-Pipeline Products by Estimated Approval Date

Figure 5: Continuous Glucose Monitoring Systems-Ongoing Clinical Trials


List Of Table

1.1 List of Tables

Table 1: Continuous Glucose Monitoring Systems-Pipeline Products by Stage of Development

Table 2: Continuous Glucose Monitoring Systems-Pipeline Products by Territory

Table 3: Continuous Glucose Monitoring Systems-Pipeline Products by Regulatory Path

Table 4: Continuous Glucose Monitoring Systems-Pipeline Products by Estimated Approval Date

Table 5: Continuous Glucose Monitoring Systems-Ongoing Clinical Trials

Table 6: Continuous Glucose Monitoring Systems Companies-Pipeline Products by Stage of Development

Table 7: Continuous Glucose Monitoring Systems-Pipeline Products by Stage of Development

Table 8: A. Menarini Diagnostics Srl Pipeline Products & Ongoing Clinical Trials Overview

Table 9: GlucoMen Day-Product Status

Table 10: GlucoMen Day-Product Description

Table 11: Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 12: FreeStyle Libre Flash Glucose Monitoring System-Children-Product Status

Table 13: FreeStyle Libre Flash Glucose Monitoring System-Children-Product Description

Table 14: FreeStyle Libre Glucose Monitoring System-Consumer Version-Product Status

Table 15: FreeStyle Libre Glucose Monitoring System-Consumer Version-Product Description

Table 16: Abbott Diabetes Care Inc-Ongoing Clinical Trials Overview

Table 17: FreeStyle Libre Flash Glucose Monitoring System-Children-A Comparative Study on the Accuracy and Usability Between the Dexcom G5 Mobile CGM System and the FreeStyle Flash Glucose Monitoring System

Table 18: FreeStyle Libre Flash Glucose Monitoring System-Children-An Evaluation of the Usability, Skin Reactions and Accuracy of the FreeStyle Libre Flash Glucose Monitoring System

Table 19: FreeStyle Libre Flash Glucose Monitoring System-Children-FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients

Table 20: FreeStyle Libre Flash Glucose Monitoring System-Children-Individualized Carbohydrate Intake Strategy to Improve Blood Glucose Control During Team Sports in Children and Adolescents with Type 1 Diabetes: A Carowanis Camp Study

Table 21: FreeStyle Libre Flash Glucose Monitoring System-Children-Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial

Table 22: FreeStyle Libre Flash Glucose Monitoring System-Children-Prediction and Prevention of Nocturnal Hypoglycemia in Persons with Type 1 Diabetes with Multiple Doses of Insulin using Machine Learning Techniques

Table 23: Advanced Biosensors-Ohio LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 24: My Medibit-Product Status

Table 25: My Medibit-Product Description

Table 26: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview

Table 27: Continuous Glucose Monitor-Product Status

Table 28: Continuous Glucose Monitor-Product Description

Table 29: Arkal Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 30: GlucoPod CGM System-Product Status

Table 31: GlucoPod CGM System-Product Description

Table 32: Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview

Table 33: CONTOUR PLUS ONE-Product Status

Table 34: CONTOUR PLUS ONE-Product Description

Table 35: Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 36: Blood Glucose Sensor-Product Status

Table 37: Blood Glucose Sensor-Product Description

Table 38: Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 39: Glucowizzard-Product Status

Table 40: Glucowizzard-Product Description

Table 41: Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview

Table 42: VSM 3 Glucose Monitoring System-Product Status

Table 43: VSM 3 Glucose Monitoring System-Product Description

Table 44: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview

Table 45: Fluorescence Measurement Device-Product Status

Table 46: Fluorescence Measurement Device-Product Description

Table 47: CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 48: Glucoband-Product Status

Table 49: Glucoband-Product Description

Table 50: CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

A. Menarini Diagnostics Srl, GlucoMen Day, Diabetes Mellitus; Abbott Diabetes Care Inc, FreeStyle Libre Flash Glucose Monitoring System - Children, Diabetes Mellitus; Abbott Diabetes Care Inc, FreeStyle Libre Glucose Monitoring System - Consumer Version, Diabetes Mellitus; Advanced Biosensors-Ohio LLC (Inactive), My Medibit, Diabetes Mellitus; Advanced Medical Electronics Corp, Continuous Glucose Monitor, Diabetes Mellitus; Arkal Medical, Inc. (Inactive), GlucoPod CGM System, MicroTip Technology, Type I Diabetes Mellitus; Arkal Medical, Inc. (Inactive), GlucoPod CGM System, MicroTip Technology, Type II Diabetes Mellitus; Ascensia Diabetes Care Holdings AG, CONTOUR PLUS ONE, No Coding Technology, Diabetes Mellitus; Azurite Technologies, Inc. (Inactive), Blood Glucose Sensor, Type I Diabetes Mellitus; Biorasis Inc, Glucowizzard, Type I Diabetes Mellitus; Biovotion AG, VSM 3 Glucose Monitoring System, Impedance Spectroscopy, Diabetes Mellitus; Brigham and Women's Hospital, Fluorescence Measurement Device, Diabetes Mellitus; CALISTO MEDICAL, INC. (Inactive), Glucoband, Bio-electromagnetic Resonance Technology, Diabetes Mellitus; CGM3 Ltd, Miniaturized Implantable Continuous Glucose Monitor, Diabetes Mellitus; City, University of London, Non-Invasive Glucose Monitor, Dynamic Pulsatile Spectroscopy (DPS) Technology, Diabetes Mellitus; Columbia University, Wearable Continuous Blood Glucose Monitoring Device, Diabetes Mellitus; ConvaTec Group Plc, Closed Loop Continuous Glucose Monitoring System, Diabetes Mellitus; Cyber Medical Ltd, Cybersensors Continuous Glucose Sensor, Biosensor Technology, Diabetes Mellitus; Debiotech SA, Integrated iSense CGM And JewelPUMP, Type I Diabetes Mellitus; Debiotech SA, Integrated iSense CGM And JewelPUMP, Type II Diabetes Mellitus; DexCom Inc, Dexcom G6 CGM System, Diabetes Mellitus; DexCom Inc, Dexcom G7 CGM System, Diabetes Mellitus; DexCom Inc, First-Gen Verily Sensor, Diabetes Mellitus; DirectSens GmbH, 3rd Generation Glucose Sensor, Diabetes Mellitus; DirectSens GmbH, Continuous Blood Glucose Monitoring System, Diabetes Mellitus; Echo Therapeutics Inc, Gen 2 Symphony CGM System, Diabetes Mellitus; Echo Therapeutics Inc, NextGen System, Diabetes Mellitus; Echo Therapeutics Inc, Symphony tCGM System - Home, Type I Diabetes Mellitus; Echo Therapeutics Inc, Symphony tCGM System - Home, Type II Diabetes Mellitus; Echo Therapeutics Inc, Symphony tCGM System - Hospital Critical Care, Type I Diabetes Mellitus; Echo Therapeutics Inc, Symphony tCGM System - Hospital Critical Care, Type II Diabetes Mellitus; Ecole Polytechnique Federale de Lausanne, Viscosimetric Glucose Sensor, Diabetes Mellitus; eLutions Integrated Systems, Inc., Optically-Efficient Miniaturized Raman Optical System, Diabetes Mellitus; EyeSense GmbH, FiberSense System, FiberSense Technology, Diabetes Mellitus; Flowsion A/S, Diramo System, Diabetes Mellitus; Flowsion A/S, Glycostat, Diabetes Mellitus; Gili Medical Ltd, Diawatch, Hypoglycemia; Globe Medical Tech Inc (Inactive), Continuous Glucose Monitoring Device, Diabetes Mellitus; GlucoLight Corporation (Inactive), SENTRIS-100, Optical Coherence Tomography Technology, Diabetes Mellitus; Glucometrix AG, Non-Invasive Blood Glucose Monitoring Device, Quantum Cascade Laser Technology, Diabetes Mellitus; Glucosense Diagnostics Ltd (Inactive), Non-Invasive Blood Glucose Monitor, Type I Diabetes Mellitus; Glucosense Diagnostics Ltd (Inactive), Non-Invasive Blood Glucose Monitor, Type II Diabetes Mellitus; GlucoSet AS, GlucoSet Sensor, Diabetes Mellitus; Glucovation Inc, SugarSenz Continuous Glucose Monitor, Diabetes Mellitus; GluMetrics Inc, GluCath Intravascular Continuous Glucose Monitor, Diabetes Mellitus; Glusense Ltd, Glyde CGM, Diabetes Mellitus; GlySens Inc, Eclipse ICGM System, Diabetes Mellitus; GlySens Inc, Second Generation ICGM System, Diabetes Mellitus; G-Sense Ltd., G-Sense Device, Diabetes Mellitus; iGlyko, Inc. (Inactive), iGlyko System, Blood-Glucose Sensor Technology, Diabetes Mellitus; Indigo Diabetes NV, Needle-Free Glucose Sensor, Diabetes Mellitus; Innovosens AB, Diabsens, Diabetes Mellitus; Insulet Corp, Integrated CGM With Next Gen OmniPod System PDM, Diabetes Mellitus; Integrated Medical Sensors, Implantable Continuous Glucose Monitor, Type I Diabetes Mellitus; Integrity Applications Ltd, GlucoTrack - DF-C, Diabetes Mellitus; Integrity Applications Ltd, GlucoTrack DF-F - Pre-diabetes, Diabetes Mellitus; Integrity Applications Ltd, GlucoTrack DF-F, Type II Diabetes Mellitus; Invivosense ASA (Inactive), IvSCGM Biosensor, Smart Hydrogel Fiber Optic Sensing Technology, Diabetes Mellitus; I-Sens Inc, Continuous Glucose Monitor, Diabetes Mellitus; iSense Corporation (Inactive), iSense CGM, Diabetes Mellitus; Keratin Biosciences Inc, Illume, MicroCHIPS Technology, Diabetes Mellitus; Know Labs Inc, UBAND, Diabetes Mellitus; KTH Royal Institute of Technology, Microneedle Patch - Glucose Monitoring, Diabetes Mellitus; LEMM Technologies, LLC, Non-Invasive Blood Glucose Monitor, Type I Diabetes Mellitus; LEMM Technologies, LLC, Non-Invasive Blood Glucose Monitor, Type II Diabetes Mellitus; Massachusetts Institute of Technology, Glucose Sensitive Tattoo, Diabetes Mellitus; Massachusetts Institute of Technology, Implantable Glucose Sensor, Diabetes Mellitus; Medical Wireless Sensing Ltd, GlucoWiSe, Diabetes Mellitus; Medtronic Diabetes, Combo Set Glucose Monitoring System, Diabetes Mellitus; Medtronic Diabetes, Enhanced Enlite Glucose Sensor, Diabetes Mellitus; Medtronic Diabetes, Guardian Connect Mobile CGM System, Diabetes Mellitus; Medtronic Diabetes, Harmony 1 Sensor, Type I Diabetes Mellitus; Medtronic Diabetes, Harmony 1 Sensor, Type II Diabetes Mellitus; Medtronic Diabetes, Harmony 2 Sensor, Diabetes Mellitus; Medtronic Diabetes, iPro 3 Glucose Monitoring System, Diabetes Mellitus; Medtronic Diabetes, ipro 4 Glucose Monitoring System, Diabetes Mellitus; Medtronic Diabetes, ipro 5 Glucose Monitoring System Sensor, Diabetes Mellitus; Medtronic Diabetes, Synergy Sensor, SmartGuard Technology, Diabetes Mellitus; Medtronic plc, Zeus Next Generation Guardian Sensor, Diabetes Mellitus; Mellitor Ltd, Mellitor Sensor, Mellitor Sensor Technology, Diabetes Mellitus; Metronom Health Inc, CGM System, Diabetes Mellitus; mobiLIFE, GlucoReader, Diabetes Mellitus; Nemaura Medical Inc, sugarBEAT, Beat Technology, Diabetes Mellitus; Newton Photonics Inc, Non-invasive Blood Glucose Monitor, Optical Coherence Tomography Technology, Diabetes Mellitus; Northwestern University, Continuous Glucose Sensor, Diabetes Mellitus; Orsus Medical Ltd, Non-Invasive Blood Glucose Monitor, Diabetes Mellitus; PKvitality, K'Watch Glucose, SkinTaste Technology, Diabetes Mellitus; PositiveID Corp, Fully Synthetic Glucose Sensing System, Diabetes Mellitus; Prediktor Medical AS, BioMKR one, Type I Diabetes Mellitus; Profusa Inc, Non-enzymatic Glucose Sensor, Diabetes Mellitus; Purdue University, Soft Contact Lens - Glucose Monitoring, Diabetes Mellitus; Purdue University, Soft Contact Lens - Glucose Monitoring, Ocular Diseases; Purdue University, Soft Contact Lens - Glucose Monitoring, Ocular Pain; San Meditech (Huzhou) Co., Ltd., Dynamic Glucose Monitoring System, Diabetes Mellitus; Senseonics Holdings Inc, Eversense XL CGM System, Diabetes Mellitus; SensiVida Medical Technologies, Inc. (Inactive), Glucose Monitoring System, Multispectral Image Processing Technology, Diabetes Mellitus; Senzime AB, CliniSenz, Biosensor Technology, Diabetes Mellitus; Singapore Biomicro Pte Ltd, Implantable Blood Glucose Monitoring Device, Diabetes Mellitus; Socrates Health Solutions, Inc., Companion CM, Diabetes Mellitus; Stony Brook University, GlucoREAD Patch, Type I Diabetes Mellitus; Stony Brook University, GlucoREAD Patch, Type II Diabetes Mellitus; Swansea University, Flash Glucose Monitoring Device, Type I Diabetes Mellitus; Swansea University, Hi-Tech Diabetes Blood Glucose Monitor, Diabetes Mellitus; Tenax Therapeutics Inc, Glucose Biosensor, Diabetes Mellitus; Terumo Corp, CMOS Image Glucose Sensor, Diabetes Mellitus; Terumo Corp, High Accuracy CGM, Diabetes Mellitus; Texas A&;M University, Minimally Invasive Glucose Monitoring System, Diabetes Mellitus; Ultradian Diagnostics LLC, Biologue, Diabetes Mellitus; University of California Berkeley, Dropsense Continuous Glucose Monitor, Diabetes Mellitus; University of California Irvine, Implantable Device - Diabetes Mellitus, Type I Diabetes Mellitus; University of California Irvine, Implantable Device - Diabetes Mellitus, Type II Diabetes Mellitus; University of California San Diego, Glucose Monitoring Tattoo, Diabetes Mellitus; University of South Carolina, Continuous Glucose Monitoring System, Diabetes Mellitus; University of South Florida, Long Term Silicon Carbide (SiC) RF Antenna, Diabetes Mellitus; University of Technology Sydney, Hypo Detection System, Hypoglycemia; University of Texas at Arlington, Nanotechnology Based Glucose Monitoring Device, Diabetes Mellitus; VeriTeQ Corporation, GlucoChip, Diabetes Mellitus; Vytrace, Inc., Continuous Glucose Monitoring Device, Diabetes Mellitus; WaveForm Technologies Inc, Continuous Glucose Monitoring System, Diabetes Mellitus; Zyvex Corp, GeNI, Diabetes Mellitus


Companies

A. Menarini Diagnostics Srl

Abbott Diabetes Care Inc

Advanced Biosensors-Ohio LLC

Advanced Medical Electronics Corp

Arkal Medical, Inc.

Ascensia Diabetes Care Holdings AG

Azurite Technologies, Inc.

Biorasis Inc

Biovotion AG

Brigham and Women's Hospital

CALISTO MEDICAL, INC.

CGM3 Ltd

City, University of London

Columbia University

ConvaTec Group Plc

Cyber Medical Ltd

Debiotech SA

DexCom Inc

DirectSens GmbH

Echo Therapeutics Inc

Ecole Polytechnique Federale de Lausanne

eLutions Integrated Systems, Inc.

EyeSense GmbH

Flowsion A/S

Gili Medical Ltd

Globe Medical Tech Inc

GlucoLight Corporation

Glucometrix AG

Glucosense Diagnostics Ltd

GlucoSet AS

Glucovation Inc

GluMetrics Inc

Glusense Ltd

GlySens Inc

G-Sense Ltd.

iGlyko, Inc.

Indigo Diabetes NV

Innovosens AB

Insulet Corp

Integrated Medical Sensors

Integrity Applications Ltd

Invivosense ASA

I-Sens Inc

iSense Corporation

Keratin Biosciences Inc

Know Labs Inc

KTH Royal Institute of Technology

LEMM Technologies, LLC

Massachusetts Institute of Technology

Medical Wireless Sensing Ltd

Medtronic Diabetes

Medtronic plc

Mellitor Ltd

Metronom Health Inc

mobiLIFE

Nemaura Medical Inc

Newton Photonics Inc

Northwestern University

Orsus Medical Ltd

PKvitality

PositiveID Corp

Prediktor Medical AS

Profusa Inc

Purdue University

San Meditech (Huzhou) Co., Ltd.

Senseonics Holdings Inc

SensiVida Medical Technologies, Inc.

Senzime AB

Singapore Biomicro Pte Ltd

Socrates Health Solutions, Inc.

Stony Brook University

Swansea University

Tenax Therapeutics Inc

Terumo Corp

Texas A&M University

Ultradian Diagnostics LLC

University of California Berkeley

University of California Irvine

University of California San Diego

University of South Carolina

University of South Florida

University of Technology Sydney

University of Texas at Arlington

VeriTeQ Corporation

Vytrace, Inc.

WaveForm Technologies Inc

Zyvex Corp